INTEGRA LIFESCIENCES HOLDINGIART
ASignal's systematic analysis rates IART as Neutral.
Reflects the latest available analysis · analyzed Sep 17, 2026
The case on IART
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Oversold RSI (28.07) suggests potential reversal
- Free cash flow positive at $94.40M
- Gross margin strong at 56.87%
- Current ratio healthy at 3.60x indicating solid short-term financial health
- MACD below signal line with negative histogram, indicating bearish momentum
- Price below both SMA20 and SMA50, signaling downtrend
- Negative net margin (-0.44%) and negative ROE (-0.70%)
- High debt-to-equity ratio (1.96x) raises financial risk concerns
- Low revenue growth (0.80% YoY) limits top-line expansion
See the full verdict on IART
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes IART
Most investors never get a second opinion, let alone several. ASignal runs IART past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.